Literature DB >> 15981101

Absence of histological signs of tumor progression in recurrences of completely resected meningiomas.

Davide Schiffer1, Chiara Ghimenti, Valentina Fiano.   

Abstract

In meningioma recurrences a tumor progression has been proposed on a molecular genetic basis. From the histological point of view the problem has not been sufficiently investigated. Recurrences mainly depend on tumor location, histology, resection type and on the tumor growth in the adjacent nervous tissue. Seventy-six completely resected recurrent meningiomas have been studied. Most tumors were convexity or parasagittal meningiomas. The number of recurrences studied per tumor varied from 1 to 5. Besides histological methods, immunohistochemistry for Ki-67 MIB-1, TUNEL for apoptosis, counts of mitoses and molecular genetics for CDKN2A were performed. No variation of the mitotic index (MI) or MIB-1 labeling index (LI) was observed in recurrences. Histological features, the number of mitoses and the MIB-1 LI showed a great regional variability. Loss of heterozygosity (LOH) of CDKN2A was found to be slightly more frequent in the first recurrence than in the initial tumor, but it was lower in the following recurrences. The nervous tissue adjacent to the tumor could contain meningothelial cells and be responsible for recurrences. The number of mitoses appeared to be the most important criterion for establishing the tumor grade. The histological aspect does not change in recurrences and there is no progression. The greater number of recurrences in atypical and anaplastic tumors depends on their initial higher proliferation capacity. The occurrence of tumor meningothelial cells in the adjacent nervous tissue or in the thickened arachnoidal membrane can be responsible for recurrence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981101     DOI: 10.1007/s11060-004-4207-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  33 in total

1.  Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas.

Authors:  P Leuraud; Y Marie; E Robin; S Huguet; J He; K Mokhtari; P Cornu; K Hoang-Xuan; M Sanson
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

Review 2.  Why do meningiomas recur?

Authors:  L Palma
Journal:  J Neurosurg Sci       Date:  2003-06       Impact factor: 2.279

3.  No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry.

Authors:  M L Møller; O Braendstrup
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

4.  Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas.

Authors:  A Konstantinidou; P Korkolopoulou; E Patsouris; H Mahera; S Hranioti; X Kotsiakis; P Davaris
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

5.  Proliferation and DNA fragmentation in meningioma subtypes.

Authors:  H Maier; J Wanschitz; R Sedivy; K Rössler; D Ofner; H Budka
Journal:  Neuropathol Appl Neurobiol       Date:  1997-12       Impact factor: 8.090

6.  The prediction of recurrence in meningiomas.

Authors:  M R Crompton; P C Gautier-Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-02       Impact factor: 10.154

7.  A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas.

Authors:  Arie Perry; Ruma Banerjee; Christine M Lohse; Bette K Kleinschmidt-DeMasters; Bernd W Scheithauer
Journal:  Brain Pathol       Date:  2002-04       Impact factor: 6.508

8.  Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labelling and immunohistochemical study.

Authors:  H K Ng; L Chen
Journal:  Histopathology       Date:  1998-07       Impact factor: 5.087

9.  Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.

Authors:  Dana Mihaila; Michelle Jankowski; Jorge A Gutiérrez; Mark L Rosenblum; Irene F Newsham; Oliver Bögler; Sandra A Rempel
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

Review 10.  Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture.

Authors:  C B Wilson
Journal:  J Neurosurg       Date:  1994-11       Impact factor: 5.115

View more
  12 in total

1.  Growth curve analysis of asymptomatic and symptomatic meningiomas.

Authors:  Satoshi Nakasu; Yoko Nakasu; Tadateru Fukami; Junya Jito; Kazuhiko Nozaki
Journal:  J Neurooncol       Date:  2010-08-05       Impact factor: 4.130

2.  Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas.

Authors:  Daina Skiriute; Sarunas Tamasauskas; Virginija Asmoniene; Viktoras Saferis; Kestutis Skauminas; Vytenis Deltuva; Arimantas Tamasauskas
Journal:  J Neurooncol       Date:  2010-07-04       Impact factor: 4.130

3.  Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype.

Authors:  Leihao Ren; Lingyang Hua; Zhongyuan Bao; Hiroaki Wakimoto; Ye Gong; Jiaojiao Deng; Daijun Wang; Jiawei Chen; Hong Chen; Tareq A Juratli
Journal:  J Neurooncol       Date:  2022-05-25       Impact factor: 4.130

4.  Two-Staged Approach for Giant Hypervascular Meningioma Resection.

Authors:  Ahmed Ansari; Sadaf Riyaz
Journal:  Asian J Neurosurg       Date:  2020-04-07

5.  Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.

Authors:  Hiromi Kanno; Hiroshi Nishihara; Lei Wang; Sayaka Yuzawa; Hiroyuki Kobayashi; Masumi Tsuda; Taichi Kimura; Mishie Tanino; Shunsuke Terasaka; Shinya Tanaka
Journal:  Neuro Oncol       Date:  2013-03-28       Impact factor: 12.300

6.  Loss of heterozygosity studies in extracranial metastatic meningiomas.

Authors:  Caroline Regna Gladin; Ettore Salsano; Francesca Menghi; Marina Grisoli; Francesco Ghielmetti; Ida Milanesi; Bianca Pollo; Stefano Brock; Alberto Cusin; Ludovico Minati; Gaetano Finocchiaro; Maria Grazia Bruzzone
Journal:  J Neurooncol       Date:  2007-04-24       Impact factor: 4.130

7.  Evaluation of neo-angiogenesis in a case of chordoid meningioma.

Authors:  Valeria Barresi; Giovanni Tuccari
Journal:  J Neurooncol       Date:  2009-06-26       Impact factor: 4.130

8.  DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.

Authors:  Francesca Menghi; Francesca N Orzan; Marica Eoli; Mariangela Farinotti; Emanuela Maderna; Federica Pisati; Donatella Bianchessi; Lorella Valletta; Sandro Lodrini; Giuseppe Galli; Elena Anghileri; Serena Pellegatta; Bianca Pollo; Gaetano Finocchiaro
Journal:  Oncologist       Date:  2011-09-23

9.  Surgical Outcome of Treating Grades II and III Meningiomas: A Report of 32 Cases.

Authors:  Konstantinos Violaris; Vasileios Katsarides; Maria Karakyriou; Pavlos Sakellariou
Journal:  Neurosci J       Date:  2012-11-05

10.  Long-term follow-up of surgical resection alone for primary intracranial rostrotentorial tumors in dogs: 29 cases (2002-2013).

Authors:  Anna Suñol; Joan Mascort; Cristina Font; Alicia Rami Bastante; Martí Pumarola; Alejandro Lujan Feliu-Pascual
Journal:  Open Vet J       Date:  2017-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.